Clinical Trials Center

CTC volunteer receiving injection from uniformed doctor

The Clinical Trials Center (CTC) was established in early 1992 to support Army and Navy investigators in their mission to develop new vaccines, drugs, and diagnostic systems to meet high-priority Department of Defense and national security needs. As part of WRAIR, the CTC is fully integrated within a network designed to bring products to market with an average of 5-10 new studies each year.

Since its inception, the CTC has conducted over 150 clinical trials of drugs and vaccines for a variety of infectious diseases, including Ebola, Japanese encephalitis, Zika, HIV and many others. 

Learn more here about holding a clinical trial at WRAIR or WRAIR's network of affiliated laboratories around the world or contact us.

Recruiting Studies

This is a phase 2 study that is intended to assess two experimental vaccines at low and high doses; the Hantaan Virus DNA Vaccine and Puumala Virus DNA Vaccine. Phase 2a means that these vaccines have been tested in humans previously, and the results showed that they were safe and well tolerated. We repeat the study with more people and different doses, to verify the safety and get more data on the best dose for protection.